Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Short-term Investments: 2020-2025

Historic Short-term Investments for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $419,000.

  • Burning Rock Biotech's Short-term Investments rose 947.50% to $419,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $419,000, marking a year-over-year increase of 947.50%. This contributed to the annual value of $317,000 for FY2024, which is 1764.71% up from last year.
  • Burning Rock Biotech's Short-term Investments amounted to $419,000 in Q3 2025, which was up 30.53% from $321,000 recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Short-term Investments high stood at $10.0 million for Q4 2021, and its period low was $8,000 during Q1 2024.
  • In the last 3 years, Burning Rock Biotech's Short-term Investments had a median value of $98,000 in 2023 and averaged $279,091.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 99.43% in 2024, then surged by 3,800.00% in 2025.
  • Over the past 5 years, Burning Rock Biotech's Short-term Investments (MRQ) stood at $10.0 million in 2021, then tumbled by 71.28% to $2.9 million in 2022, then tumbled by 99.41% to $17,000 in 2023, then skyrocketed by 1,764.71% to $317,000 in 2024, then skyrocketed by 32.18% to $419,000 in 2025.
  • Its Short-term Investments stands at $419,000 for Q3 2025, versus $321,000 for Q2 2025 and $312,000 for Q1 2025.